152 related articles for article (PubMed ID: 4093702)
1. Effects of low-dose human chorionic gonadotropin on corpus luteum function after embryo transfer.
Mahadevan MM; Leader A; Taylor PJ
J In Vitro Fert Embryo Transf; 1985 Dec; 2(4):190-4. PubMed ID: 4093702
[TBL] [Abstract][Full Text] [Related]
2. Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles.
Fujimoto A; Osuga Y; Fujiwara T; Yano T; Tsutsumi O; Momoeda M; Kugu K; Koga K; Morita Y; Wada O; Taketani Y
J Assist Reprod Genet; 2002 Dec; 19(12):550-4. PubMed ID: 12503886
[TBL] [Abstract][Full Text] [Related]
3. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.
Herman A; Raziel A; Strassburger D; Soffer Y; Bukovsky I; Ron-El R
Hum Reprod; 1996 Jul; 11(7):1552-7. PubMed ID: 8671503
[TBL] [Abstract][Full Text] [Related]
4. Enhanced oestradiol secretion briefly after embryo transfer in conception cycles from IVF.
Greb RR; Lettmann N; Sonntag B; Schüring AN; von Otte S; Kiesel L
Reprod Biomed Online; 2004 Sep; 9(3):271-8. PubMed ID: 15353074
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.
Araujo E; Bernardini L; Frederick JL; Asch RH; Balmaceda JP
J Assist Reprod Genet; 1994 Feb; 11(2):74-8. PubMed ID: 7819706
[TBL] [Abstract][Full Text] [Related]
6. Effect of combined exogenous progesterone with luteotrophic support via equine chorionic gonadotrophin (eCG) on corpus luteum development, circulating progesterone concentrations and embryo development in cattle.
O'Hara L; Forde N; Duffy P; Randi F; Kelly AK; Valenza A; Rodriguez P; Lonergan P
Reprod Fertil Dev; 2016 Mar; 28(3):269-77. PubMed ID: 25033944
[TBL] [Abstract][Full Text] [Related]
7. Active corpus luteum function at pre-, peri- and postimplantation is essential for a viable pregnancy.
Liu HC; Pyrgiotis E; Davis O; Rosenwaks Z
Early Pregnancy; 1995 Dec; 1(4):281-7. PubMed ID: 9363260
[TBL] [Abstract][Full Text] [Related]
8. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.
Balasch J; Creus M; Fábregues F; Carmona F; Casamitjana R; Peñarrubia J; Rivera F; Vanrell JA
Gynecol Endocrinol; 1995 Mar; 9(1):51-8. PubMed ID: 7793300
[TBL] [Abstract][Full Text] [Related]
9. Luteal phase hormonal profile in prediction of pregnancy outcome after assisted reproduction.
Vicdan K; Zeki Isik A
Eur J Obstet Gynecol Reprod Biol; 2001 May; 96(1):98-101. PubMed ID: 11311769
[TBL] [Abstract][Full Text] [Related]
10. The efficiency of human reproduction after in vitro fertilization and embryo transfer.
Liu HC; Jones HW; Rosenwaks Z
Fertil Steril; 1988 Apr; 49(4):649-53. PubMed ID: 3350159
[TBL] [Abstract][Full Text] [Related]
11. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.
Valbuena D; Pellicer A; Guanes PP; Remohí J; Simón C
Hum Reprod; 1997 Oct; 12(10):2118-22. PubMed ID: 9402265
[TBL] [Abstract][Full Text] [Related]
12. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
13. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
[TBL] [Abstract][Full Text] [Related]
14. Luteal-phase support in stimulated cycles in an in vitro fertilization/embryo transfer program: progesterone versus human chorionic gonadotropin.
Nader S; Berkowitz AS; Ochs D; Held B; Winkel CA
J In Vitro Fert Embryo Transf; 1988 Apr; 5(2):81-4. PubMed ID: 3411179
[TBL] [Abstract][Full Text] [Related]
15. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
Claman P; Domingo M; Leader A
Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
[TBL] [Abstract][Full Text] [Related]
16. Corpus luteum response to exogenous HCG during the mid-luteal phase of the menstrual cycle.
Tay PY; Lenton EA
Clin Endocrinol (Oxf); 2000 Sep; 53(3):345-50. PubMed ID: 10971452
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of human chorionic gonadotropin support following in vitro fertilization and embryo transfer.
Buvat J; Marcolin G; Herbaut JC; Dehaene JL; Verbecq P; Fourlinnie JC
Fertil Steril; 1988 Mar; 49(3):458-61. PubMed ID: 3277865
[TBL] [Abstract][Full Text] [Related]
18. Luteal function following ovarian stimulation in rhesus monkeys for in vitro fertilization: atypical response to human chorionic gonadotropin treatment simulating early pregnancy.
VandeVoort CA; Hess DL; Stouffer RL
Fertil Steril; 1988 Jun; 49(6):1071-5. PubMed ID: 3131158
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between serum progesterone level at the day with human chorionic gonadotrophin administration and the outcome of pregnancy in in-vitro fertilization].
Xi QP; Mao YD; Gao Y; Ding W; Wang W; Ma X; Diao FY; Huang J; Qian XQ; Cai LB; Feng T; Yan ZJ; Liu JY
Zhonghua Fu Chan Ke Za Zhi; 2010 Feb; 45(2):118-23. PubMed ID: 20420782
[TBL] [Abstract][Full Text] [Related]
20. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
